Car T-Cell Therapy Cost in India
Starting from USD 45,000 – USD 85,000
Unlock Exclusive Discount : Your Gateway to Premium Healthcare with Medsurge India Health Value Card.
Unlock Exclusive Discount : Your Gateway to Premium Healthcare with Medsurge India Health Value Card.
Searching for affordable CAR T-cell therapy in India? India has rapidly advanced in the field of cellular immunotherapy and now offers state-of-the-art CAR T-cell treatment in internationally accredited cancer centers. This breakthrough therapy is primarily used for relapsed or resistant blood cancers, especially certain types of Non-Hodgkin lymphoma, Hodgkin lymphoma, and specific leukemias.
With highly trained hemato-oncologists, specialized transplant units, and modern cell-processing laboratories, India delivers advanced CAR T-cell therapy at a fraction of the cost seen in Western countries.
The average cost of CAR T-cell therapy in India ranges between $45,000 to $85,000 (INR 41 Lakh to INR 78 Lakh), depending on the specific CAR T product, hospital infrastructure, patient’s medical condition, and post-infusion care needs.
CAR T-cell therapy is generally advised when standard treatments such as chemotherapy, targeted therapy, or stem cell transplant have not produced the desired response.
Top cancer hospitals in India provide advanced ICU backup, infection-controlled units, and continuous monitoring systems to safely administer this highly specialized treatment.
Patients undergo detailed medical assessment, eligibility screening, and multidisciplinary case review before proceeding with therapy.
The overall expense may vary based on:
The following are the key components involved in CAR T-cell therapy in India, along with their approximate costs:
| Treatment Component | Approx. Cost (USD) |
| Pre-treatment Evaluation | $1,500 to $3,000 |
| T-cell Collection (Apheresis) | $3,500 to $6,000 |
| Genetic Modification & Processing | $25,000 to $40,000 |
| CAR T-Cell Infusion | $2,000 to $5,000 |
| ICU Monitoring & Supportive Care | $3,000 to $8,000 |
Treatment costs may slightly differ across major metropolitan cities due to infrastructure and hospital facilities.
| City | Approx. Cost |
| Delhi | $45,000 to $80,000 |
| Mumbai | $50,000 to $85,000 |
| Chennai | $45,000 to $75,000 |
| Bangalore | $45,000 to $75,000 |
Costs vary depending on transplant capabilities, ICU infrastructure, and oncology expertise.
| Top Hospitals | Approx. Cost |
| Artemis Hospital Gurgaon | $50,000 to $80,000 |
| Fortis Memorial Research Institute, Gurgaon | $50,000 to $85,000 |
| Medanta – The Medicity Hospital, Gurgaon | $55,000 to $85,000 |
| Max Hospital Saket, New Delhi | $50,000 to $80,000 |
| MGM Healthcare, Chennai | $50,000 to $75,000 |
| Global Hospital Chennai | $50,000 to $75,000 |
| Apollo Hospitals, Greams Road, Chennai | $55,000 to $85,000 |
| Shalby Sanar International Hospital, Gurgaon | $50,000 to $80,000 |
| Manipal Hospital Gurgaon | $50,000 to $80,000 |
CAR T-Cell Therapy Cost in India for International Patients
For overseas patients, the total cost may include additional coordination services and extended hospital monitoring. Even so, CAR T-cell therapy in India remains substantially more economical compared to the US, UK, and Europe.
In Western countries, the cost of CAR T-cell therapy is significantly high. Luckily, this is available in India at a much more affordable cost, i.e., 1/4th from other countries. Thus making it a safe, effective, and affordable option for both domestic and international patients. The table below highlights the approximate cost difference:
| Country | Approx. Surgery Cost |
| India | $45,000 to $85,000 |
| USA | $3,50,000 to $5,00,000 |
| UK | $3,00,000 to $4,50,000 |
| Germany | $2,50,000 to $4,00,000 |
| UAE | $1,20,000 to $1,80,000 |
Note: Actual costs may vary by hospital, procedure type, and individual treatment plan.
Know More:- NexCAR19 India’s First Living Drug For Cancer Treatment
CAR T-cell therapy is a highly specialized form of immunotherapy that uses the patient’s own immune cells to fight cancer. In this treatment, T cells are collected from the bloodstream, modified in a laboratory to better recognize cancer cells, and then reinfused into the body to attack the disease.
Also Read:- Best Oncologists in India
The success of CAR T cell therapy depends on the type and stage of blood cancer at diagnosis. CAR T-cell therapy has demonstrated encouraging remission rates in patients with relapsed or treatment-resistant blood cancers, particularly in high-risk cases where conventional treatments have limited effectiveness.
For example, early-stage Hodgkin lymphoma has a high cure rate of over 85–90%, while many Non-Hodgkin lymphoma subtypes respond well to modern treatments.
Recovery varies depending on the treatment type. Chemotherapy cycles are spread over several months, and most patients gradually regain strength with regular follow-up. Recovery after CAR T cell therapy requires close monitoring for a few weeks to manage possible immune-related side effects.
Bone marrow or stem cell transplant recovery can take several months, with ongoing follow-up care to ensure full recovery and long-term health.
Why Choose India for CAR T-Cell Therapy?
India is a preferred destination for CAR T-cell therapy due to:
India combines medical expertise, advanced technology, and affordability, making it a reliable destination for CAR T cell therapy.
India has emerged as a trusted destination for advanced cellular immunotherapy, including CAR T-cell therapy. This therapy in India is offered at leading cancer centers equipped with modern infrastructure and strict monitoring protocols to manage immune-related side effects effectively.
If you or your loved one is considering CAR T-cell therapy for relapsed or treatment-resistant blood cancers, our team can support you with eligibility assessment, hospital selection guidance, transparent cost estimates, visa assistance, and end-to-end treatment coordination to ensure a smooth and well-organized medical journey in India.
| Estimate Type | Estimated Cost (USD) |
|---|---|
| Total Package Estimate | USD 45,000 – USD 85,000* |
*Final cost depends on hospital, patient condition, and additional procedures.
Estimated cost range in India: USD 45,000 – USD 85,000*
*For accurate quote, share your reports and preferred city/hospital.
The CAR T-cell therapy cost typically depends on the type of cancer, the patient’s clinical condition, the hospital chosen, and supportive care requirements.
It is recommended for patients with relapsed or treatment-resistant blood cancers who have not responded to standard therapies.
Yes, it is administered under strict medical supervision with ICU monitoring to manage potential immune-related reactions.
The complete process, including evaluation, cell collection, modification, infusion, and monitoring, usually takes several weeks.
Surgical Oncologist
Senior Consultant
14+ years
TX Hospitals, Banjara Hills
View Doctor
Surgical Oncologist
Senior Consultant
12+ Years
BLK Max Super Speciality Hospital, New Delhi
View Doctor
Medical Oncologist
Associate Consultant
10+ years
Meitra Hospital, Calicut, Kerala
View Doctor
Radiation Oncologist
Senior Consultant
10+ years
Apollo Proton Cancer Centre, Chennai
View Doctor
Surgical Oncologist
Senior Consultant
8+ years
Meitra Hospital, Calicut, Kerala
View Doctor
Medical Oncologist
Consultant
15+ years
Care Hospitals HITEC City
View Doctor
Surgical Oncologist
Sr. Consultant & Associate Clinical Director
20+ years
Care Hospitals HITEC City
View Doctor
By using our site, you agree to our Terms and Conditions, Privacy Policy and Refund Policy. Medsurge India provides reliable healthcare information and treatment options to support informed decision-making. Our content is designed to support and complement the guidance of your treating doctor, helping you feel informed and confident throughout your healthcare journey. We also Accept International Payments.
Copyright © 2025 NSM ONLINE SOLUTIONS PRIVATE LIMITED. All rights reserved.
 (1).png)